It looks like you're offline.
Open Library logo
additional options menu

MARC Record from marc_columbia

Record ID marc_columbia/Columbia-extract-20221130-014.mrc:64538491:5762
Source marc_columbia
Download Link /show-records/marc_columbia/Columbia-extract-20221130-014.mrc:64538491:5762?format=raw

LEADER: 05762cam a22004454a 4500
001 6787510
005 20221122052020.0
008 080222t20082008nyua bf 001 0 eng
010 $a 2008008242
016 7 $a101466798$2DNLM
019 $a144216826
020 $a9781420051445 (hardcover : alk. paper)
020 $a142005144X (hardcover : alk. paper)
029 1 $aNLM$b101466798
035 $a(OCoLC)ocn212376023
035 $a(OCoLC)212376023$z(OCoLC)144216826
035 $a(NNC)6787510
035 $a6787510
040 $aDNLM/DLC$cDLC$dNLM$dBAKER$dBTCTA$dYDXCP$dC#P$dOrLoB-B
042 $apcc
050 00 $aRC628$b.H289 2008
060 10 $aWD 210$bH2362 2008
082 00 $a616.3/98$222
245 00 $aHandbook of obesity :$bclinical applications /$cedited by George A. Bray, Claude Bouchard.
250 $a3rd ed.
260 $aNew York :$bInforma Healthcare,$c[2008], ©2008.
300 $axii, 659 pages :$billustrations ;$c29 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $gPt. I.$tEvaluation of the Overweight or Obese Patient --$g1.$tClassification and Evaluation of the Overweight Patient /$rGeorge A. Bray --$g2.$tWaist Girth: A Critical Evaluation of Usefulness /$rMarie-France Hivert and James B. Meigs --$g3.$tGenetic Evaluation of Obese Patients /$rI. Sadaf Farooqi and Stephen O'Rahilly --$g4.$tCultural Differences as Influences on Approaches to Obesity Treatment /$rShiriki Kumanyika --$g5.$tBias, Discrimination, and Obesity /$rRebecca M. Puhl and Kelly D. Brownell --$g6.$tImpact of Voluntary Weight Loss on Morbidity and Mortality /$rEdward W. Gregg --$g7.$tWeight Cycling as an Instance of False Hope /$rJanet Polivy and C. Peter Herman --$g8.$tObesity and the Primary Care Physician /$rRobert F. Kushner and Louis J. Aronne --$gPt. II.$tPrevention of Obesity --$g9.$tThe Prevention of Obesity in Childhood and Adolescence /$rTim Lobstein --$g10.$tPrevention of Obesity /$rW. Philip T. James and Timothy P. Gill --$g11.$tAnalyzing and Influencing Obesogenic Environments /$rBoyd Swinburn and Garry Egger --$g12.$tReengineering the Built Environment: Schools, Worksites, Neighborhoods, and Parks /$rDeborah A. Cohen --$g13.$tAgriculture and the Food Industry's Role in America's Weight Pandemic /$rJames E. Tillotson --$gPt. III.$tMedical Management of Obesity --$g14.$tBehavioral Approaches to the Treatment of Obesity /$rRena R. Wing --$g15.$tPreventing Weight Regain After Weight Loss /$rMichael G. Perri, John P. Foreyt and Stephen D. Anton --$g16.$tDiet Composition and Weight Loss /$rAngela P. Makris, Gary D. Foster and Arne Astrup --$g17.$tExercise and Weight Management /$rTim Church --$g18.$tSibutramine in the Management of Obesity /$rDonna H. Ryan --$g19.$tDrugs That Modify Fat Absorption and Alter Metabolism /$rGeorge A. Bray and Luc F. Van Gaal --$g20.$tCannabinoid Receptor Antagonists as Potential Antiobesity Agents /$rGeorge A. Bray --$g21.$tIntegrated Neurohormonal Approach to the Treatment of Obesity: The Amylin Agonist Pramlintide and Its Interactions with Leptin and PYY Signaling Pathways /$rJonathan D. Roth, Christine Mack, Nicole C. Kesty, David G. Parkes and Christian Weyer --$g22.$tNeuropeptide Y in the Management of Obesity /$rIra Gantz and Ngozi E. Erondu --$g23.$tSerotonin Receptor Modulation in the Treatment of Obesity /$rJason C. G. Halford and John E. Blundell --$g24.$tMelanocortin-4 Receptor as a New Target for Drug Development /$rTung M. Fong and Alison Strack --$g25.$tHistamine H[subscript 3] Receptor Antagonists in the Treatment of Obesity /$rKarin Rinivall, Rolf Hohlweg and Kjell Malmlof --$g26.$tDrugs with Thermogenic Properties /$rArne Astrup and Soren Toubro --$g27.$tStrategies to Reduce Calories in Food /$rAlexandra G. Kazaks and Judith S. Stern --$g28.$tHerbal and Alternative Approaches to Obesity /$rFrank Greenway and David Heber --$g29.$tIs There a Future for Gene Therapy in Obesity? /$rSergei Zolotukhin --$g30.$tPrevention and Management of Dyslipidemia and the Metabolic Syndrome in Obese Patients /$rScott M. Grundy --$gPt. IV.$tSurgery --$g31.$tSurgical Treatment and Comorbidities /$rHenry Buchwald --$g32.$tSwedish Obese Subjects: A Review of Results from a Prospective Controlled Intervention Trial /$rLars Sjostrom --$g33.$tLaparoscopic Adjustable Gastric Banding /$rPaul E. O'Brien --$g34.$tEvolving Surgical Therapy for Obesity /$rMichael J. Barker and Walter J. Pories --$g35.$tLiposuction and Obesity /$rLuigi Fontana and Samuel Klein --$gPt. V.$tSpecial Issues --$g36.$tObesity and Binge Eating Disorder /$rJanet D. Latner and G. Terence Wilson --$g37.$tSpecial Issues in Treatment of Pediatric Obesity /$rRobert E. Kramer and Stephen R. Daniels --$g38.$tWeight Loss Clinics: Range of Capabilities, Benefits, Risks, and Costs /$rKen Fujioka --$g39.$tEconomic Aspects of Obesity /$rPing Zhang and Rui Li --$g40.$tGovernment's Evolving Role: Nutrition, Education, Regulation, Monitoring, and Research /$rCatherine E. Woteki, Sandra S. Jones and M. R. C. Greenwood.
650 0 $aObesity$vHandbooks, manuals, etc.
650 12 $aObesity$xtherapy.$0https://id.nlm.nih.gov/mesh/D009765Q000628
650 22 $aAnti-Obesity Agents$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D019440Q000627
650 22 $aObesity$xprevention & control.$0https://id.nlm.nih.gov/mesh/D009765Q000517
655 2 $aStatistics.$0https://id.nlm.nih.gov/mesh/D020500
700 1 $aBray, George A.$0http://id.loc.gov/authorities/names/n50045553
700 1 $aBouchard, Claude.$0http://id.loc.gov/authorities/names/n50045262
856 42 $3Publisher description$uhttp://www.loc.gov/catdir/enhancements/fy0810/2008008242-d.html
852 00 $boff,hsl$hRC628$i.H29 2008 Q